Laekna, Inc.
Laekna, Inc. has 1 licensing announcement in this dataset, dated 2026-06-10.
- Country / operating region
- China
- Ticker
- 02105.HK
- Headquarters
- 查無
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- www.laekna.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| LAE118 | PI3K alpha pan-mutant | small molecule | 查無 | 2026-06-10 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Vasque Bio, Inc. | LAE118 | USD 10m | 查無 | ≤ USD 517m | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| Vasque Bio, Inc. | Worldwide excluding mainland China, Hong Kong, Macau and Taiwan | Single-digit to double-digit tiered royalties on future net sales. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無